Literature DB >> 6807688

Human endothelial cell proliferation inhibiting activity in the sera of patients suffering from 'shock' or 'sepsis'.

U Schöffel, K H Kopp, H Männer, F Vogel, C Mittermayer.   

Abstract

The response of DNA-synthesis of human endothelial cells to sera derived from twenty-five patients suffering from 'sepsis' or 'shock' was measured by autoradiographic methods. In eight cases a constant decrease in proliferative response was found compared to that of sera from healthy donors. These proliferation values were shown to lie below the '60%-of-control-line'. The difference between the means of control and of corresponding 'low-response' values was significant (P less than 0.05). In three cases a diminished response was caused only by some of several serum samples taken at different times. These results correlated well with the clinical state and outcome of patients but not with any of the over sixty clinical, therapeutic, laboratory and post-mortem parameters of investigation. Evidence is presented for a proliferation inhibiting activity in sera of patients in clinically poor states, and some physico-chemical properties of this 'factor' are described. Lethal injury to the cells or an impairment of cellular migration could not be observed within the observation periods used in this study.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6807688     DOI: 10.1111/j.1365-2362.1982.tb00954.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  2 in total

1.  [Septic shock and multiple organ failure in surgical intensive care. An animal experiment model on the analysis of pulmonary and intestinal dysfunction].

Authors:  C Töns; B Klosterhalfen; U Klinge; C J Kirkpatrick; C Mittermayer; V Schumpelick
Journal:  Langenbecks Arch Chir       Date:  1993

2.  MicroRNA-17-3p suppresses NF-κB-mediated endothelial inflammation by targeting NIK and IKKβ binding protein.

Authors:  Yin Cai; Yu Zhang; Hui Chen; Xing-Hui Sun; Peng Zhang; Lu Zhang; Meng-Yang Liao; Fang Zhang; Zheng-Yuan Xia; Ricky Ying-Keung Man; Mark W Feinberg; Susan Wai-Sum Leung
Journal:  Acta Pharmacol Sin       Date:  2021-02-23       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.